A Comparison of the Post-Marketing Safety of Four Selective Serotonin Re-Uptake Inhibitors Including the Investigation of Symptoms Occurring on Withdrawal
British Journal of Clinical Pharmacology - United Kingdom
doi 10.1046/j.1365-2125.1996.00498.x
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 1, 1996
Authors
Publisher
Wiley